Highly sensitive H2O2-scavenging nano-bionic system for precise treatment of atherosclerosis

© 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V..

In atherosclerosis, chronic inflammatory processes in local diseased areas may lead to the accumulation of reactive oxygen species (ROS). In this study, we devised a highly sensitive H2O2-scavenging nano-bionic system loaded with probucol (RPP-PU), to treat atherosclerosis more effectively. The RPP material had high sensitivity to H2O2, and the response sensitivity could be reduced from 40 to 10 μmol/L which was close to the lowest concentration of H2O2 levels of the pathological environment. RPP-PU delayed the release and prolonged the duration of PU in vivo. In Apolipoprotein E deficient (ApoE‒/‒) mice, RPP-PU effectively eliminated pathological ROS, reduced the level of lipids and related metabolic enzymes, and significantly decreased the area of vascular plaques and fibers. Our study demonstrated that the H2O2-scavenging nano-bionic system could scavenge the abundant ROS in the atherosclerosis lesion, thereby reducing the oxidative stress for treating atherosclerosis and thus achieve the therapeutic goals with atherosclerosis more desirably.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:13

Enthalten in:

Acta pharmaceutica Sinica. B - 13(2023), 1 vom: 14. Jan., Seite 372-389

Sprache:

Englisch

Beteiligte Personen:

Liang, Xiaoyu [VerfasserIn]
Li, Huiyang [VerfasserIn]
Li, Xuanling [VerfasserIn]
Tian, Xinxin [VerfasserIn]
Zhang, Aiai [VerfasserIn]
Luo, Qingzhi [VerfasserIn]
Duan, Jianwei [VerfasserIn]
Chen, Youlu [VerfasserIn]
Pang, Liyun [VerfasserIn]
Li, Chen [VerfasserIn]
Liang, Xing-Jie [VerfasserIn]
Zeng, Yong [VerfasserIn]
Yang, Jing [VerfasserIn]

Links:

Volltext

Themen:

Atherosclerosis
H2O2-scavenging
Highly sensitive
Journal Article
Nano-bionic system
Oxidative stress
Pathological environment
Precise
Target

Anmerkungen:

Date Revised 24.02.2023

published: Print-Electronic

Citation Status PubMed-not-MEDLINE

doi:

10.1016/j.apsb.2022.04.002

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM353213020